Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
MNPR compared with BCRX: revenue, margins and what each company keeps, and the suppliers and customers both name
MNPR
Monopar Therapeutics
Change
Mkt cap
Revenue
Revenue
BCRX
Biocryst Pharmaceuticals Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
MNPR
Monopar Therapeutics
vs
BCRX
Biocryst Pharmaceuticals Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes
Method
›
Moved together
MNPR
with
BCRX
Uncorrelated: r 0.04 · 499D.
No shared co-movers.
MNPR, solid
BCRX, hatched
r = correlation
Bar = r to r 0.75
Source: daily closes
MNPR
Monopar Therapeutics
Change
71.11
▲
+5.79%
· post 71.11
Mkt cap
$451.2M
Revenue
—
Revenue
—
BCRX
Biocryst Pharmaceuticals Inc
Change
7.67
▲
+0.58%
· post 7.67
Closed
Nov 6 '26
Mkt cap
$2.0B
Revenue
$180M
Q3 FY26
Revenue
$875M
FY25
vs
Compare
Closed
Nov 6 '26
MNPR
Monopar Therapeutics
vs
BCRX
Biocryst Pharmaceuticals Inc
71.11
▲
+5.79%
post 71.11
Price
7.67
▲
+0.58%
post 7.67
$451.2M
Mkt cap
$2.0B
—
Revenue
$180M
Q3 FY26
—
Revenue
$875M
FY25
Change
Change
MNPR
71.11
▲
+5.79%
vs
BCRX
7.67
▲
+0.58%
Closed
Nov 6 '26